Search results for: 'both'

This Research Service (RS) offers a strategic perspective on the global emerging industry of biomaterial technologies for various medical applications. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and industry perspectives. The third chapter brings out the syn...

This Research Service (RS) offers a strategic perspective on the global emerging industry of bionics technologies. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and end-user perspectives. The third chapter brings out the competitive landscape, focusing on strat...

This strategic analysis service provides detailed analysis of world oligonucleotides markets and includes both RNA and DNA oligos markets. The service in powerpoint format (approximately 115 slides) focuses not just only on the oligonucleotides markets but also on strategies for differentiation amongst oligonucleotides suppliers/manufacturers.

This study provides a comprehensive overview of the commercial market for lung, breast and colorectal cancer medicines responding to both cytotoxic and hormonal therapies. Researched countries are Mexico, Brazil, and Argentina. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, ...

After many years of basic research, regenerative medicine represents a remarkable foremost innovation in medical care. Comprising principles of stem cell technology and tissue engineering, also combining advanced biomaterials with small molecules and biologics, to replace or regenerate human tissues and organs and restore their functions, regenerat...

The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...

This research service profiles the emerging diagnostic ultrasound imaging technology and brings out the advancements in diagnostic ultrasound imaging . Diagnostic imaging capabilities of ultrasound has spread across all clinical applications starting from obstetrics and gynaecology, orthopaedics, cardiology, to emergency medicine, prostrate cancer...

The global healthcare industry is in need of solutions that augment providers with insights to make meaningful clinical decisions within less turnaround times, which is critical to demonstrating value of care. Artificial Intelligence has proven its utility in performing data-mining activities on large sets of patient and population health data, add...

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with...